Professional Documents
Culture Documents
Lab 6 7 8 Liver Functions Test
Lab 6 7 8 Liver Functions Test
Serum Bilirubin
Bilirubin is a yellow pigment that is in every ones blood and stool. Sometimes
the liver cannot process the bilirubin in the body because of excess bilirubin, an
obstruction, or an inflamed liver. Bilirubin is made in the body when old red
blood cells are broken down. The breakdown of old cells is a normal, healthy
process. When your body has too much bilirubin, your skin and the whites of
your eyes will start to yellow. This condition is called jaundice.
The bilirubin molecule formed in the spleen is called indirect or
unconjugated bilirubin. After circulating in your blood, bilirubin then travels
to your liver. Bilirubin conjugated with glucuronic acid by glucuronyl transferase
enzyme (by forming an ester linkage between glucuronic acid and the propionic
acid side chain of bilirubin) is called direct or conjugated bilirubin. In the
liver, bilirubin is excreted into the bile duct and is excreted into the duodenom
where conjugated bilirubin is converted by bacteria into urobilinogen and
urobilin. Urobilin is excreted with feces while urobilinogen is reabsorbed from
the liver to the blood stream and excreted via the kidney.
If bilirubin is not conjugated with glucuronic acid in the liver or is not being
adequately removed from the blood, it can mean that there is damage to your
liver. Testing for bilirubin in the blood is therefore a good test of damage to your
liver.
Clinical significance:
The determination of serum bilirubin is employed for the detection on
subclinical or occult jaundice, which characterize by founding orange dye on
the skin the sclera and the mucous membranes. Hyperbilirubinemia is
frequently will found in the following types of jaundice:
1. Hemolytic jaundice:
Caused by over production of bilirubin due to excessive hemolysis. Occur
in acute and chronic hemolytic anemia. This condition is usually
associated with increased value of serum indirect bilirubin.
2. Hepatic jaundice:
Caused by some type of intra hepatic obstruction which leads to cirrhosis
of liver and hepatitis. The production of bilirubin is not increased, but
accumulates and it discharged back into the blood. In these conditions.
The indirect bilirubin predominates in the early phase, but as the liver
damage progresses, the direct form also becomes elevated.
3. Obstructive jaundice:
Caused by a post hepatic blockage of the large bile passages, particularly
the common bile duct resulting in a reflex of bilirubin into the blood. This
condition is associated with elevated of serum direct bilirubin only.
Van Den Bergh and his co- workers applied the diazo reaction in 1913 (first
used by Ehrlich in 1883). The diazo reaction is:
H2SO3
NaNO2
DSA
Both forms of the bilirubin (direct and total bilirubin) give a pink azo bilirubin
with diazotrized sulfanilic acid.
conditions where cells of the liver have been inflamed or undergone cell death.
As the cells are damaged, the ALT leaks into the bloodstream leading to a rise
in the serum levels. Any form of hepatic cell damage can result in an elevation
in ALT. ALT is the most sensitive marker for liver cell damage.
Clinical applications of ALT assays are confined mainly to evaluation of
hepatic disorders.
Higher elevations are found in hepatocellular disorders than in extra
hepatic or intra hepatic obstructive disorders.
In acute inflammatory conditions of the liver, ALT elevated higher than
AST. (More specific than AST).
It catalyzes the transfer of amino group from L- alanine to - ketoglutarate, the
products of this reversible transamination reaction being pyruvate and Lglutamate.
The GPT activity in tissues is generally less than GOT. Significant elevation of
SGPT occurs in sever acute hepatitis where the enzyme is released into the
circulation. However GPT level is increased in the following diseases:
1. Infection hepatitis.
2. Liver cirrhosis and billiard cirrhosis.
3. Obstructive jaundice.
Clinical signification
Vit.C deficiency.
Chronic nephritis.
Hyperparathyroidism.
Kwashiorkor.
Sever anemia.
Principle:
King Armstrong method:
During incubation with ALP, the almost colorless substrate, p-nitro phenyl
phosphate, is hydrolyzed to p-nitro phenol, which is yellow in alkaline solution.
Addition of NaOH stops the enzyme reaction and beings out the product color
which measured at 405 nm.